Literature DB >> 17027041

Neutrophil-activating activity and platelet-activating factor synthesis in cytokine-stimulated endothelial cells: reduced activity in growth-arrested cells.

Tatsuji Takahashi1, Yoshiki Nishizawa, Fumihiko Hato, Haruo Shintaku, Nobuji Maeda, Nagatoshi Fujiwara, Masaaki Inaba, Kazuo Kobayashi, Seiichi Kitagawa.   

Abstract

The reactivity of endothelial cells (ECs) to proinflammatory cytokines is critically important for the pathogenesis of vascular diseases. Here, we studied functional alterations of human ECs during culture under a confluent condition; i.e., the alterations of neutrophil-activating activity, platelet-activating factor (PAF) synthesis, and granulocyte-macrophage colony-stimulating factor (GM-CSF) production in cytokine-stimulated ECs. Human umbilical vein-derived ECs exhibited the increased activity in neutrophil activation, PAF synthesis, and GM-CSF production when stimulated by proinflammatory cytokines such as interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha). The activity of cytokine-stimulated ECs to stimulate superoxide release in human neutrophils and to produce PAF declined markedly in parallel as ECs became growth-arrested during culture under a confluent condition. By contrast, GM-CSF production induced by cytokine stimulation was modestly increased, and up-regulation of intercellular adhesion molecule-1 (ICAM-1) and activation of mitogen-activated protein kinases were not altered. The neutrophil-activating activity of cytokine-stimulated ECs was dependent on PAF synthesis and GM-CSF production from ECs. These findings indicate that the reduced neutrophil-activating activity in growth-arrested ECs may be, at least in part, ascribed to down-regulation of PAF synthesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027041     DOI: 10.1016/j.mvr.2006.08.002

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  4 in total

1.  A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain.

Authors:  Brett A Thibodeaux; Nina C Garbino; Nathan M Liss; Joseph Piper; Carol D Blair; John T Roehrig
Journal:  Vaccine       Date:  2012-03-13       Impact factor: 3.641

2.  Interleukin-1β is associated with coronary endothelial dysfunction in patients with mTOR-inhibitor-eluting stent implantation.

Authors:  Hidetoshi Chibana; Hidemi Kajimoto; Takafumi Ueno; Shinji Yokoyama; Ken-Ichiro Sasaki; Masanori Ohtsuka; Hiroshi Koiwaya; Takaharu Nakayoshi; Yoshiaki Mitsutake; Naoki Itaya; Masahiro Sasaki; Yoshihiro Fukumoto
Journal:  Heart Vessels       Date:  2017-01-23       Impact factor: 2.037

Review 3.  Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy.

Authors:  Paraskevi Detopoulou; Tzortzis Nomikos; Elizabeth Fragopoulou; Christina Chrysohoou; Smaragdi Antonopoulou
Journal:  Curr Heart Fail Rep       Date:  2013-06

Review 4.  Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis.

Authors:  Chary Lopez-Pedrera; Nuria Barbarroja; Alejandra M Patiño-Trives; Maria Luque-Tévar; Eduardo Collantes-Estevez; Alejandro Escudero-Contreras; Carlos Pérez-Sánchez
Journal:  Int J Mol Sci       Date:  2020-11-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.